Celiac Disease: a model autoimmune disease with gene therapy applications
Authors:
- 1 May 2003
- journal article
- review article
- Published by Springer Nature in Gene Therapy
- Vol. 10 (10) , 835-843
Abstract
Gene therapy (GT) is still at the 'experimental' stage and some recent setbacks have cooled the potential use of this therapeutic tool even in life-threatening conditions. However, this therapeutic approach has a potential, which is not limited to disease for which we have not other option. There are increasing evidence that GT will be soon used in diseases that are not life threatening. One group of diseases that can benefit from GT is the autoimmune one. Several experimental animal models have indicated the efficacy (proof of principle) of GT. In the present review, we have addressed the possibility that even extremely benign autoimmune-like diseases such as Celiac Disease (CD) might one day profit from this type of therapy. We further point that in conditions such as CD, where the trigger is well known and the pathogenic cascade is relatively well defined, a situation not common in autoimmunity, we can even have a better situation where to explore and use GT to control disease initiation and progression. Once the risks that are still intrinsic to GT will have been reduced the therapeutic options we outline in the present review might not appear too far from reality.Keywords
This publication has 67 references indexed in Scilit:
- Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritisJournal of Clinical Investigation, 2001
- FAS engagement drives apoptosis of enterocytes of coeliac patientsGut, 2001
- Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphomaThe Lancet, 2000
- Costimulation of Transduced T Lymphocytes via T Cell Receptor-CD3 Complex and CD28 Leads to Increased Transcription of Integrated RetrovirusHuman Gene Therapy, 1999
- Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICAScience, 1999
- Improved method for serological testing in celiac disease: IgA anti-endomysium antibody test: a comparison between monkey oesophagus and human umbilical cord as substrate in indirect immunofluorescence testScandinavian Journal of Clinical and Laboratory Investigation, 1998
- Human self-reactive T cell clones expressing identical T cell receptor beta chains differ in their ability to recognize a cryptic self-epitope.Journal of Experimental Medicine, 1996
- T cell recognition of carbohydrates on type II collagen.Journal of Experimental Medicine, 1994
- Bone Marrow Transplantation—Past, Present and FutureScandinavian Journal of Immunology, 1994
- Reaction of human non-collagenous polypeptides with coeliac disease autoantibodiesThe Lancet, 1991